Showing results (71-80 of 458) with videos related to
Sort By:
Pageof 46
Cancer Research|October 16, 2003
Ferredoxin reductase: pharmacogenomic assessment in colorectal cancerJinsheng Yu, Sharon Marsh, Ranjeet Ahluwalia, et al.Peerj|May 3, 2013
Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cellsGeorge W Small, Howard L McLeod, Kristy L RichardsScience Translational Medicine|June 14, 2013
Genomic medicine: a decade of successes, challenges, and opportunitiesJeanette J McCarthy, Howard L McLeod, Geoffrey S GinsburgNature Reviews. Cancer|July 25, 2009
CYP2D6 and tamoxifen: DNA matters in breast cancerJanelle M Hoskins, Lisa A Carey, Howard L McLeodCurrent Topics in Medicinal Chemistry|September 24, 2004
Pharmacogenomics: the influence of genomic variation on drug responseFabienne J Thomas, Howard L McLeod, James W WattersPharmacogenomics|April 6, 2013
Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapyStefanie D Krens, Howard L McLeod, Daniel L HertzPharmacogenomics|July 27, 2017
Prospect for immune checkpoint blockade: dynamic and comprehensive monitorings pave the wayWeili Wang, Jie Liu, Yijing He, et al.Breast (Edinburgh, Scotland)|November 17, 2009
Pharmacogenetics of breast cancer therapiesDaniel L Hertz, Howard L McLeod, Janelle M HoskinsAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2002
Genetic basis of drug metabolismMargaret K Ma, Michael H Woo, Howard L McLeodThe Oncologist|April 26, 2012
Tamoxifen and CYP2D6: a contradiction of dataDaniel L Hertz, Howard L McLeod, William J IrvinPageof 46